XML 55 R20.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED STATEMENTS OF CONSOLIDATED CASH FLOWS (Unaudited) - CERC - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Flows from Operating Activities:    
Net Income $ 297 $ 350
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 363 363
Deferred income taxes 45 193
Changes in other assets and liabilities:    
Accounts receivable and unbilled revenues, net (125) 72
Inventory 110 93
Taxes receivable 40 (110)
Accounts payable (216) (70)
Current regulatory assets and liabilities 64 (97)
Non-current regulatory assets and liabilities 1 (48)
Other operating activities, net 1 (20)
Net cash provided by operating activities 410 538
Cash Flows from Investing Activities:    
Capital expenditures (1,038) (845)
Proceeds from divestiture 1,219 0
Other investing activities, net (58) 1
Net cash used in investing activities (234) (844)
Cash Flows from Financing Activities:    
Decrease in short-term borrowings, net (3) (4)
Payments of long-term debt and term loans, including make-whole premiums (11) (22)
Proceeds from commercial paper, net 569 157
Other financing activities, net (16) (27)
Net cash used in financing activities 1,053 376
Net Increase in Cash, Cash Equivalents and Restricted Cash 1,229 70
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 30 109
Cash, Cash Equivalents and Restricted Cash at End of Period 1,259 179
Supplemental Disclosure of Cash Flow Information    
Cash paid for interest, net of capitalized interest 290 228
Supplemental Disclosure of Non-cash Transactions    
Accounts payable related to capital expenditures 334 195
CERC    
Cash Flows from Operating Activities:    
Net Income 305 264
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 142 127
Deferred income taxes 26 106
Loss on sale (52) 0
Changes in other assets and liabilities:    
Accounts receivable and unbilled revenues, net (139) 21
Accounts receivable/payable–affiliated companies (19) 18
Inventory 82 82
Taxes receivable 46 (36)
Accounts payable (24) (81)
Current regulatory assets and liabilities 78 (94)
Non-current regulatory assets and liabilities 75 25
Other current assets and liabilities (20) (53)
Other non-current assets and liabilities 78 12
Other operating activities, net 0 (13)
Net cash provided by operating activities 578 378
Cash Flows from Investing Activities:    
Capital expenditures (311) (303)
Decrease (increase) in notes receivable–affiliated companies (1,222) 1
Proceeds from divestiture 1,219 0
Other investing activities, net (46) 13
Net cash used in investing activities (360) (289)
Cash Flows from Financing Activities:    
Decrease in short-term borrowings, net (3) (4)
Payments of long-term debt and term loans, including make-whole premiums (10) 0
Proceeds from commercial paper, net (107) 48
Dividends to parent (97) (115)
Other financing activities, net (2) (2)
Net cash used in financing activities (219) (73)
Net Increase in Cash, Cash Equivalents and Restricted Cash (1) 16
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 2 1
Cash, Cash Equivalents and Restricted Cash at End of Period 1 17
Supplemental Disclosure of Cash Flow Information    
Cash paid for interest, net of capitalized interest 90 76
Supplemental Disclosure of Non-cash Transactions    
Accounts payable related to capital expenditures $ 80 $ 59